.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
McKinsey
Healthtrust
US Department of Justice
QuintilesIMS
Accenture
Argus Health
Express Scripts
Farmers Insurance
Moodys

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 010669

« Back to Dashboard
NDA 010669 describes LEUKERAN, which is a drug marketed by Aspen Global Inc and is included in one NDA. It is available from one supplier. Additional details are available on the LEUKERAN profile page.

The generic ingredient in LEUKERAN is chlorambucil. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the chlorambucil profile page.

Summary for NDA: 010669

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details

Pharmacology for NDA: 010669

Mechanism of ActionAlkylating Activity

Suppliers and Packaging for NDA: 010669

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LEUKERAN
chlorambucil
TABLET;ORAL 010669 NDA Aspen Global Inc. 76388-635 76388-635-25 25 TABLET, FILM COATED in 1 BOTTLE (76388-635-25)
LEUKERAN
chlorambucil
TABLET;ORAL 010669 NDA Aspen Global Inc. 76388-635 76388-635-50 50 TABLET, FILM COATED in 1 BOTTLE (76388-635-50)

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Express Scripts
Harvard Business School
Fish and Richardson
Baxter
US Army
McKinsey
Cerilliant
UBS
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot